Showing results (171-180 of 233) with videos related to

Sort By:
Pageof 24
Medical Care|January 10, 2004
Clinical Risk Groups (CRGs): a classification system for risk-adjusted capitation-based payment and health care managementJohn S Hughes, Richard F Averill, Jon Eisenhandler, et al.
Biology of Reproduction|December 22, 2023
The role of the aryl hydrocarbon receptor in mediating the effects of mono(2-ethylhexyl) phthalate in mouse ovarian antral follicles†Alison M Neff, Zane Inman, Vasiliki E Mourikes, et al.
Circulation|June 15, 1995
An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkeyJ J Cook, G R Sitko, B Bednar, et al.
Pediatrics|November 18, 2015
Comparison of Health Care Spending and Utilization Among Children With Medicaid InsuranceDennis Z Kuo, Matt Hall, Rishi Agrawal, et al.
Obesity Pillars|October 27, 2025
Exploring the role of digital health technologies in assessing functional mobility and physical activity: Insights from qualitative interviews in adults with obesity or overweightJeremiah J Trudeau, Brian Winger, Theresa Hunter Gibble, et al.
Obesity Pillars|November 11, 2025
Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trialIris A Goetz, Chisom Kanu, Anastasia Hoover, et al.
International Journal of Molecular Sciences|October 13, 2021
Pistil Mating Type and Morphology Are Mediated by the Brassinosteroid Inactivating Activity of the S-Locus Gene BAHD in Heterostylous Turnera SpeciesCourtney M Matzke, Hasan J Hamam, Paige M Henning, et al.
ANNA Journal|August 1, 1992
Images of nephrology nursing practice: report of a surveyS Taylor, D Breckenridge, E Butera, et al.
American Journal of Preventive Medicine|September 29, 2018
Dietary Approaches to Stop Hypertension Diet and Activity to Limit Gestational Weight: Maternal Offspring Metabolics Family Intervention Trial, a Technology Enhanced Randomized TrialLinda Van Horn, Alan Peaceman, Mary Kwasny, et al.
Diabetes, Obesity & Metabolism|September 13, 2023
Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trialEmily R Hankosky, Hui Wang, Lisa M Neff, et al.
Pageof 24